Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-25 @ 9:09 PM
Study NCT ID:
NCT05804656
Status:
COMPLETED
Last Update Posted:
2023-12-12
First Post:
2023-03-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial
Sponsor:
CKD Bio Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-13
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-20
Completion Date Type:
ACTUAL
First Submit Date:
2023-03-27
First Submit QC Date:
None
Study First Post Date:
2023-04-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-11
Last Update Post Date:
2023-12-12
Last Update Post Date Type:
ACTUAL